Spyridakos, D.; Mastrodimou, N.; Vemuri, K.; Ho, T.C.; Nikas, S.P.; Makriyannis, A.; Thermos, K.
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. Int. J. Mol. Sci. 2023, 24, 240.
https://doi.org/10.3390/ijms24010240
AMA Style
Spyridakos D, Mastrodimou N, Vemuri K, Ho TC, Nikas SP, Makriyannis A, Thermos K.
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International Journal of Molecular Sciences. 2023; 24(1):240.
https://doi.org/10.3390/ijms24010240
Chicago/Turabian Style
Spyridakos, Dimitris, Niki Mastrodimou, Kiran Vemuri, Thanh C. Ho, Spyros P. Nikas, Alexandros Makriyannis, and Kyriaki Thermos.
2023. "Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats" International Journal of Molecular Sciences 24, no. 1: 240.
https://doi.org/10.3390/ijms24010240
APA Style
Spyridakos, D., Mastrodimou, N., Vemuri, K., Ho, T. C., Nikas, S. P., Makriyannis, A., & Thermos, K.
(2023). Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International Journal of Molecular Sciences, 24(1), 240.
https://doi.org/10.3390/ijms24010240
